Early-stage and emerging pharma companies must design supply chains that can support rapid growth, late-stage clinical milestones, and the transition to commercial production—all while operating with lean teams and limited infrastructure. This panel brings together biotech supply chain leaders to discuss how they build foundational processes, choose the right partners, manage risk with small volumes, and establish the capabilities needed for future scale.

• Establish essential supply chain capabilities early, including forecasting, quality systems, material planning, logistics, and supplier management
• Leverage partners strategically to close capability gaps without overbuilding internal teams too soon
• Prepare for scale-up by designing flexible processes and networks that can grow with portfolio and demand complexity

Biotech and small pharma companies rely heavily on external partners to deliver manufacturing, packaging, testing, storage, and distribution. This panel explores how smaller organizations can build productive, transparent, and resilient relationships with CMOs, CDMOs, and 3PLs. Speakers will discuss how to negotiate the right service models, maintain quality oversight, manage variability, and ensure alignment between internal priorities and partner workflows.

• Strengthen CMO/CDMO/3PL partnerships through clear expectations, shared KPIs, and structured governance
• Maintain quality and compliance standards even with highly outsourced supply chains
• Mitigate dependency risks by diversifying partners, developing backup capacity, and improving transparency